Technical Analysis for LJPC - La Jolla Pharmaceutical Company

Grade Last Price % Change Price Change
grade C 7.73 -2.21% -0.18
LJPC closed down 2.21 percent on Friday, January 17, 2020, on 85 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical LJPC trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Boomer Buy Setup Bullish Swing Setup -2.21%
Calm After Storm Range Contraction -2.21%
Upper Bollinger Band Walk Strength -2.21%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for chronic organ failure and cancer. The company's products include GCS-100, a Phase-1/2 clinical trial drug used for the treatment of chronic kidney disease. It also provides LJPC-501, a peptide agonist of the renin-angiotensin system, which is designed to help restore kidney function in patients with hepatorenal syndrome. In addition, the company is developing LJPC-101, a subcutaneous formulation of GCS-100; LJPC-201, an oral galectin-3 inhibitor; and LJPC-301, a monoclonal antibody designed to neutralize galectin-3. La Jolla Pharmaceutical Company was founded in 1989 and is headquartered in San Diego, California.
Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Medication Chronic Kidney Disease Peptide Hormones Proteins Lectins Galectin Galectin 3 Hepatorenal Syndrome

Is LJPC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.88
52 Week Low 2.3
Average Volume 1,371,720
200-Day Moving Average 7.53
50-Day Moving Average 4.75
20-Day Moving Average 5.11
10-Day Moving Average 6.25
Average True Range 0.64
ADX 35.78
+DI 48.05
-DI 9.20
Chandelier Exit (Long, 3 ATRs ) 7.07
Chandelier Exit (Short, 3 ATRs ) 5.56
Upper Bollinger Band 8.50
Lower Bollinger Band 1.72
Percent B (%b) 0.89
BandWidth 132.69
MACD Line 0.93
MACD Signal Line 0.46
MACD Histogram 0.4724
Fundamentals Value
Market Cap 171.01 Million
Num Shares 22.1 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -1.51
Price-to-Sales 5475.91
Price-to-Book 5.28
PEG Ratio -0.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.33
Resistance 3 (R3) 8.37 8.22 8.23
Resistance 2 (R2) 8.22 8.06 8.19 8.19
Resistance 1 (R1) 7.97 7.97 7.90 7.93 8.16
Pivot Point 7.82 7.82 7.78 7.80 7.82
Support 1 (S1) 7.57 7.66 7.50 7.53 7.30
Support 2 (S2) 7.42 7.57 7.40 7.27
Support 3 (S3) 7.18 7.42 7.23
Support 4 (S4) 7.13